• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克氏锥虫 UDP-半乳糖吡喃糖变位酶的晶体结构揭示组氨酸环的灵活性在酶激活中的作用。

Crystal structures of Trypanosoma cruzi UDP-galactopyranose mutase implicate flexibility of the histidine loop in enzyme activation.

机构信息

Department of Chemistry, University of Missouri-Columbia, Columbia, Missouri 65211, USA.

出版信息

Biochemistry. 2012 Jun 19;51(24):4968-79. doi: 10.1021/bi300498c. Epub 2012 Jun 5.

DOI:10.1021/bi300498c
PMID:22646091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3426654/
Abstract

Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi. Here we report crystal structures of the galactofuranose biosynthetic enzyme UDP-galactopyranose mutase (UGM) from T. cruzi, which are the first structures of this enzyme from a protozoan parasite. UGM is an attractive target for drug design because galactofuranose is absent in humans but is an essential component of key glycoproteins and glycolipids in trypanosomatids. Analysis of the enzyme-UDP noncovalent interactions and sequence alignments suggests that substrate recognition is exquisitely conserved among eukaryotic UGMs and distinct from that of bacterial UGMs. This observation has implications for inhibitor design. Activation of the enzyme via reduction of the FAD induces profound conformational changes, including a 2.3 Å movement of the histidine loop (Gly60-Gly61-His62), rotation and protonation of the imidazole of His62, and cooperative movement of residues located on the si face of the FAD. Interestingly, these changes are substantially different from those described for Aspergillus fumigatus UGM, which is 45% identical to T. cruzi UGM. The importance of Gly61 and His62 for enzymatic activity was studied with the site-directed mutant enzymes G61A, G61P, and H62A. These mutations lower the catalytic efficiency by factors of 10-50, primarily by decreasing k(cat). Considered together, the structural, kinetic, and sequence data suggest that the middle Gly of the histidine loop imparts flexibility that is essential for activation of eukaryotic UGMs. Our results provide new information about UGM biochemistry and suggest a unified strategy for designing inhibitors of UGMs from the eukaryotic pathogens.

摘要

恰加斯病是一种被忽视的热带病,由原生动物寄生虫克氏锥虫引起。在这里,我们报告了克氏锥虫半乳糖呋喃糖生物合成酶 UDP-半乳糖吡喃糖变位酶(UGM)的晶体结构,这是该酶来自原生动物寄生虫的第一个结构。UGM 是药物设计的一个有吸引力的靶点,因为半乳糖呋喃糖在人类中不存在,但它是锥虫生物中关键糖蛋白和糖脂的重要组成部分。对酶-UDP 非共价相互作用和序列比对的分析表明,底物识别在真核 UGM 中高度保守,与细菌 UGM 不同。这一观察结果对抑制剂设计具有重要意义。通过还原 FAD 激活酶会引起深刻的构象变化,包括组氨酸环(Gly60-Gly61-His62)的 2.3 Å 移动、His62 的咪唑的旋转和质子化以及位于 FAD si 面的残基的协同运动。有趣的是,这些变化与曲霉 UGM 描述的变化有很大不同,曲霉 UGM 与 T. cruzi UGM 的同一性为 45%。用定点突变酶 G61A、G61P 和 H62A 研究了 Gly61 和 His62 对酶活性的重要性。这些突变使催化效率降低了 10-50 倍,主要是通过降低 k(cat)。综合来看,结构、动力学和序列数据表明,组氨酸环的中间 Gly 赋予了真核 UGM 激活所必需的灵活性。我们的结果提供了关于 UGM 生物化学的新信息,并提出了一种从真核病原体设计 UGM 抑制剂的统一策略。

相似文献

1
Crystal structures of Trypanosoma cruzi UDP-galactopyranose mutase implicate flexibility of the histidine loop in enzyme activation.克氏锥虫 UDP-半乳糖吡喃糖变位酶的晶体结构揭示组氨酸环的灵活性在酶激活中的作用。
Biochemistry. 2012 Jun 19;51(24):4968-79. doi: 10.1021/bi300498c. Epub 2012 Jun 5.
2
Contributions of unique active site residues of eukaryotic UDP-galactopyranose mutases to substrate recognition and active site dynamics.真核生物尿苷二磷酸半乳糖吡喃糖变位酶独特活性位点残基对底物识别和活性位点动力学的贡献。
Biochemistry. 2014 Dec 16;53(49):7794-804. doi: 10.1021/bi501008z. Epub 2014 Dec 2.
3
Substrate-dependent dynamics of UDP-galactopyranose mutase: Implications for drug design.基于底物的 UDP-半乳糖吡喃糖变位酶动力学:对药物设计的启示。
Protein Sci. 2013 Nov;22(11):1490-501. doi: 10.1002/pro.2332. Epub 2013 Sep 17.
4
Crystal structures and small-angle x-ray scattering analysis of UDP-galactopyranose mutase from the pathogenic fungus Aspergillus fumigatus.UDP-半乳糖吡喃糖变位酶的晶体结构与小角 X 射线散射分析来自致病真菌烟曲霉。
J Biol Chem. 2012 Mar 16;287(12):9041-51. doi: 10.1074/jbc.M111.327536. Epub 2012 Jan 31.
5
Identification of the NAD(P)H binding site of eukaryotic UDP-galactopyranose mutase.鉴定真核 UDP-半乳糖吡喃糖变位酶的 NAD(P)H 结合位点。
J Am Chem Soc. 2012 Oct 31;134(43):18132-8. doi: 10.1021/ja308188z. Epub 2012 Oct 19.
6
Structural insight into the unique substrate binding mechanism and flavin redox state of UDP-galactopyranose mutase from Aspergillus fumigatus.曲霉 UDP-半乳糖吡喃糖变位酶独特的底物结合机制和黄素氧化还原态的结构见解。
J Biol Chem. 2012 Mar 30;287(14):10780-90. doi: 10.1074/jbc.M111.322974. Epub 2012 Feb 10.
7
Chemical mechanism of UDP-galactopyranose mutase from Trypanosoma cruzi: a potential drug target against Chagas' disease.克氏锥虫尿苷二磷酸半乳糖变位酶的化学机制:一种针对恰加斯病的潜在药物靶点。
PLoS One. 2012;7(3):e32918. doi: 10.1371/journal.pone.0032918. Epub 2012 Mar 20.
8
Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase.酶促化学合成、抑制研究及 UDP-Galp 膦酸类似物的 X 射线晶体学分析作为 UDP-半乳糖吡喃糖变位酶的抑制剂和作用机制探针。
J Mol Biol. 2010 Nov 5;403(4):578-90. doi: 10.1016/j.jmb.2010.08.053. Epub 2010 Sep 17.
9
Conformational Control of UDP-Galactopyranose Mutase Inhibition.UDP-吡喃半乳糖变位酶抑制作用的构象控制
Biochemistry. 2017 Aug 1;56(30):3983-3992. doi: 10.1021/acs.biochem.7b00189. Epub 2017 Jul 20.
10
Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP.底物与UDP-吡喃半乳糖变位酶结合的结构基础:与UDP-吡喃半乳糖和UDP复合的还原态和氧化态晶体结构
J Mol Biol. 2009 Dec 18;394(5):864-77. doi: 10.1016/j.jmb.2009.10.013. Epub 2009 Oct 21.

引用本文的文献

1
Galactofuranosidases: From the Initial Activity Detection to the First Crystalline Structure.半乳呋喃糖苷酶:从最初的活性检测到首个晶体结构
ACS Omega. 2025 Jul 11;10(28):29969-29979. doi: 10.1021/acsomega.5c04674. eCollection 2025 Jul 22.
2
Structural bioinformatics insights into UDP-galactopyranose mutase (UGM) as a novel drug target for antifilarial therapy against human filarial parasite Brugia malayi.基于结构生物信息学对UDP-吡喃半乳糖变位酶(UGM)的见解:作为抗人类丝虫寄生虫马来布鲁线虫抗丝虫治疗的新型药物靶点
Mol Divers. 2025 Jul 24. doi: 10.1007/s11030-025-11304-5.
3
N5 Is the New C4a: Biochemical Functionalization of Reduced Flavins at the N5 Position.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Chemical mechanism of UDP-galactopyranose mutase from Trypanosoma cruzi: a potential drug target against Chagas' disease.克氏锥虫尿苷二磷酸半乳糖变位酶的化学机制:一种针对恰加斯病的潜在药物靶点。
PLoS One. 2012;7(3):e32918. doi: 10.1371/journal.pone.0032918. Epub 2012 Mar 20.
3
Structural insight into the unique substrate binding mechanism and flavin redox state of UDP-galactopyranose mutase from Aspergillus fumigatus.
N5即新的C4a:还原型黄素在N5位的生化功能化修饰
Front Mol Biosci. 2020 Oct 30;7:598912. doi: 10.3389/fmolb.2020.598912. eCollection 2020.
4
The Glycan Structure of mucins Depends on the Host. Insights on the Chameleonic Galactose.粘蛋白的聚糖结构取决于宿主。关于变色龙半乳糖的新见解。
Molecules. 2020 Aug 27;25(17):3913. doi: 10.3390/molecules25173913.
5
Molecular Dynamics Simulations of Substrate Release from Trypanosoma cruzi UDP-Galactopyranose Mutase.从克氏锥虫 UDP-半乳糖吡喃糖变位酶中释放基质的分子动力学模拟。
J Chem Inf Model. 2019 Feb 25;59(2):809-817. doi: 10.1021/acs.jcim.8b00675. Epub 2019 Jan 17.
6
Steric Control of the Rate-Limiting Step of UDP-Galactopyranose Mutase.UDP-吡喃半乳糖变位酶限速步骤的空间控制
Biochemistry. 2018 Jul 3;57(26):3713-3721. doi: 10.1021/acs.biochem.8b00323. Epub 2018 May 18.
7
Multiple functionalities of reduced flavin in the non-redox reaction catalyzed by UDP-galactopyranose mutase.UDP-吡喃半乳糖变位酶催化的非氧化还原反应中还原型黄素的多种功能。
Arch Biochem Biophys. 2017 Oct 15;632:59-65. doi: 10.1016/j.abb.2017.06.015. Epub 2017 Jun 24.
8
Conformational Control of UDP-Galactopyranose Mutase Inhibition.UDP-吡喃半乳糖变位酶抑制作用的构象控制
Biochemistry. 2017 Aug 1;56(30):3983-3992. doi: 10.1021/acs.biochem.7b00189. Epub 2017 Jul 20.
9
The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations.植物次生代谢产物作为抗原生动物被忽视疾病的药物或先导化合物的潜力——第三部分:计算机辅助分子对接研究
Molecules. 2016 Oct 19;21(10):1389. doi: 10.3390/molecules21101389.
10
In Crystallo Capture of a Covalent Intermediate in the UDP-Galactopyranose Mutase Reaction.在晶体中捕获UDP-吡喃半乳糖变位酶反应中的共价中间体。
Biochemistry. 2016 Feb 16;55(6):833-6. doi: 10.1021/acs.biochem.6b00035. Epub 2016 Feb 4.
曲霉 UDP-半乳糖吡喃糖变位酶独特的底物结合机制和黄素氧化还原态的结构见解。
J Biol Chem. 2012 Mar 30;287(14):10780-90. doi: 10.1074/jbc.M111.322974. Epub 2012 Feb 10.
4
Crystal structures and small-angle x-ray scattering analysis of UDP-galactopyranose mutase from the pathogenic fungus Aspergillus fumigatus.UDP-半乳糖吡喃糖变位酶的晶体结构与小角 X 射线散射分析来自致病真菌烟曲霉。
J Biol Chem. 2012 Mar 16;287(12):9041-51. doi: 10.1074/jbc.M111.327536. Epub 2012 Jan 31.
5
Nucleophilic participation of reduced flavin coenzyme in mechanism of UDP-galactopyranose mutase.还原黄素辅酶在 UDP-半乳糖吡喃糖变位酶机制中的亲核参与。
J Biol Chem. 2012 Feb 10;287(7):4602-8. doi: 10.1074/jbc.M111.312538. Epub 2011 Dec 20.
6
Galactofuranose in eukaryotes: aspects of biosynthesis and functional impact.真核生物中的半乳糖呋喃糖:生物合成和功能影响的各个方面。
Glycobiology. 2012 Apr;22(4):456-69. doi: 10.1093/glycob/cwr144. Epub 2011 Sep 22.
7
Biosynthesis of galactofuranose in kinetoplastids: novel therapeutic targets for treating leishmaniasis and chagas' disease.动质体中半乳呋喃糖的生物合成:治疗利什曼病和恰加斯病的新治疗靶点。
Enzyme Res. 2011;2011:415976. doi: 10.4061/2011/415976. Epub 2011 May 25.
8
Chagas disease has now gone global.恰加斯病现已蔓延至全球。
PLoS Negl Trop Dis. 2011 Apr 26;5(4):e1136. doi: 10.1371/journal.pntd.0001136.
9
Protonation, tautomerization, and rotameric structure of histidine: a comprehensive study by magic-angle-spinning solid-state NMR.组氨酸的质子化、互变异构和构象异构体:魔角旋转固态 NMR 的综合研究。
J Am Chem Soc. 2011 Feb 9;133(5):1534-44. doi: 10.1021/ja108943n. Epub 2011 Jan 5.
10
Flavin redox switching of protein functions.蛋白质功能的黄素氧化还原开关。
Antioxid Redox Signal. 2011 Mar 15;14(6):1079-91. doi: 10.1089/ars.2010.3417. Epub 2010 Oct 28.